Revenge of the gram-negatives!

A new report for the pharmaceutical industry states that the market for drugs to treat hospital-acquired gram-negative organisms will increase by $1 billion over the next 10 years. The report notes that the market for gram-positive drugs has been more lucrative, but now the opportunities for gram-positive drugs are declining. Let's hope that Pharma is successful in its quest for new gram-negative drugs given the worsening problems we are encountering with highly resistant gram-negative infections and few agents available currently for their treatment.


Most Read Posts (Last 30 Days)